Literature DB >> 26947140

N-Acyl ethanolamide and eicosanoid involvement in irritant dermatitis.

A C Kendall1, S M Pilkington2,3, G Sassano4, L E Rhodes2,3, A Nicolaou1.   

Abstract

BACKGROUND: Sodium lauryl sulfate (SLS) and ultraviolet radiation (UVR) are two commonly encountered cutaneous inflammatory stimuli. Differing histopathological and clinical features implicate involvement of alternative inflammatory pathways; bioactive lipid mediators (eicosanoids, endocannabinoids and sphingolipids) are likely candidates for regulation of the divergent inflammatory responses.
OBJECTIVES: To assess comprehensively bioactive lipid involvement in SLS- and UVR-induced inflammatory responses, to provide a better understanding of bioactive lipid mediator pathways in irritant inflammation.
METHODS: Buttock skin from 10 healthy volunteers was treated with two minimal erythema doses of UVR (275-380 nm, peak 305 nm) or an SLS dose optimized for each individual, to produce a comparable, moderate erythema. Punch biopsies were taken 24 h postchallenge and from untreated skin, and separated into dermis and epidermis. Lipids [including 15 prostanoids, 15 hydroxy fatty acids (HFAs), nine endocannabinoids and related N-acyl ethanolamides (NAE), and 21 sphingolipids] were extracted and quantified using liquid chromatography-tandem mass spectrometry.
RESULTS: Increased epidermal NAE and HFA expression was observed in response to SLS but not UVR-induced low-level inflammation. Significant changes following SLS treatment included augmented levels of NAE, possessing proinflammatory and some reported anti-inflammatory properties, with 3·7-fold (P = 0·02) and threefold (P = 0·01) increased expression of palmitoyl and stearoyl ethanolamides, respectively, in addition to 1·9-fold (P = 0·02) increased expression of 12-hydroxyeicosatetraenoic acid.
CONCLUSIONS: The differential bioactive lipid upregulation implicates their involvement in skin irritant responses, potentially reflecting roles in inflammatory cell recruitment and subsequent resolution of inflammation, giving scope for new treatment approaches to irritant dermatitis.
© 2016 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26947140     DOI: 10.1111/bjd.14521

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

Review 1.  Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.

Authors:  Kinga Fanni Tóth; Dorottya Ádám; Tamás Bíró; Attila Oláh
Journal:  Molecules       Date:  2019-03-06       Impact factor: 4.927

2.  Lipid functions in skin: Differential effects of n-3 polyunsaturated fatty acids on cutaneous ceramides, in a human skin organ culture model.

Authors:  Alexandra C Kendall; Magdalena Kiezel-Tsugunova; Luke C Brownbridge; John L Harwood; Anna Nicolaou
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-03-21       Impact factor: 3.747

3.  Cannabidiol Effects on Phospholipid Metabolism in Keratinocytes from Patients with Psoriasis Vulgaris.

Authors:  Iwona Jarocka-Karpowicz; Michał Biernacki; Adam Wroński; Agnieszka Gęgotek; Elżbieta Skrzydlewska
Journal:  Biomolecules       Date:  2020-02-28

4.  Dynamics of the human skin mediator lipidome in response to dietary ω-3 fatty acid supplementation.

Authors:  Suzanne M Pilkington; Sharon A Murphy; Alexandra C Kendall; Francesco Del Carratore; Anggit L Sunarwidhi; Magdalena Kiezel-Tsugunova; Paula Urquhart; Rachel E B Watson; Rainer Breitling; Lesley E Rhodes; Anna Nicolaou
Journal:  FASEB J       Date:  2019-09-13       Impact factor: 5.191

Review 5.  Current knowledge of the implication of lipid mediators in psoriasis.

Authors:  Mélissa Simard; Sophie Morin; Zainab Ridha; Roxane Pouliot
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

Review 6.  Contact dermatitis.

Authors:  Pamela L Scheinman; Marc Vocanson; Jacob P Thyssen; Jeanne Duus Johansen; Rosemary L Nixon; Kate Dear; Nina C Botto; Johanna Morot; Ari M Goldminz
Journal:  Nat Rev Dis Primers       Date:  2021-05-27       Impact factor: 52.329

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.